Among the top stories in hematology/oncology last week were the FDA granting fast track designation to CLR 131 for the treatment of diffuse large B-cell lymphoma and a Q&A focusing on a virtual program that provides nutritional and wellness support for patients with cancer.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
At Issue: Melanoma Resource Center
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.